Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
暂无分享，去创建一个
R. Schilsky | C. Calfa | K. Gogineni | Monika L. Burness | J. Krishnamurthy | A. Gaba | N. Rohatgi | Dominique C. Hinshaw | T. Al Baghdadi | M. Rothe | G. N. Grantham | Susan Halabi | Ramya Thota | Philip J Gold | P. Mangat | Abigail Gregory | E.R. Ahn | E. Garrett-Mayer | Omid Hamid | J. Rodón | A. Conlin | N. Gavini | Jens Rueter